Pyrazinamide
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6412 publications
Pyrazinamide resistance and treatment outcomes among people with drug-resistant TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: October 31, 2026
Sequential Drug Rechallenge Identifying Unusually Concomitant Rifampicin and Pyrazinamide Hepatotoxicity in a Patient Treated for Ganglionar Tuberculosis.
Journal: American journal of therapeutics
Published: October 16, 2026
Severe Inflammatory Response and Moderate Acute Respiratory Distress Syndrome (ARDS) in an Immunocompetent Patient With Disseminated Tuberculosis: A Case Report.
Journal: Cureus
Published: September 20, 2026
Pyrazine-Based Chemosensors for Cation Detection.
Journal: Molecules (Basel, Switzerland)
Published: September 12, 2026
Drug-Induced Liver Injury During First-Line Anti-Tubercular Therapy (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol): A Case Report with De-challenge and Rechallenge.
Journal: EJIFCC
Published: September 05, 2026
Maleylated-BSA-Coated Gold Nanopopcorns for Pulmonary Delivery of Quercetin.
Journal: International journal of molecular sciences
Published: September 03, 2026
Pediatric Mycobacterium bovis Infection: Clinical Spectrum, BCG-Related Disease, Primary Immunodeficiency, and a Comprehensive Review of the Literature.
Journal: Vaccines
Published: August 27, 2026
Drug resistance of clinical Mycobacterium tuberculosis isolates and molecular characteristics of rifampicin-resistant isolates from elderly pulmonary tuberculosis patients in Beijing, 2024
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: August 19, 2026
Last Updated: 11/08/2026